Publication|Articles|August 6, 2023
- Pharmaceutical Executive: August 2023
- Volume 43
- Issue 8
Pharmaceutical Executive, August 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive August 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
Executive Roundtable: Innovations in Global Pharma Labelingalmost 3 years ago
A Fierce Focus On Unmet Needalmost 3 years ago
Pharma's ESG Equation: Materiality and Strategy are Keyalmost 3 years ago
Bridging the Divide: Medical's Omnichannel Momentumalmost 3 years ago
AI and Drug 'Re-Innovation'almost 3 years ago
More Evidence is Pointing to Potential Swing for Biotechalmost 3 years ago
2023 Proxy Season: Record Proposals, Sliding Supportalmost 3 years ago
Do Findings Point to a Tarnished COVID Victory for Europe?almost 3 years ago
Harnessing the Power of Communities to Combat Healthcare InequitiesAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How MBA Graduates Can Break into Competitive Industries in 2026: 4 Practical Steps
2
Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Secures $21 Million Series A
3
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5

